Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Multiple Sclerosis

  Free Subscription


1 BMC Neurol
1 Lancet Neurol
1 Mult Scler
1 Nat Rev Neurol
2 Neurologia (Engl Ed)
1 Neurology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. VASANTHAPRASAD V, Khurana V, Vadapalle S, Palace J, et al
    Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.
    BMC Neurol. 2022;22:301.
    PubMed         Abstract available

    Lancet Neurol

  2. GORIS A, Vandebergh M, McCauley JL, Saarela J, et al
    Genetics of multiple sclerosis: lessons from polygenicity.
    Lancet Neurol. 2022;21:830-842.
    PubMed         Abstract available

    Mult Scler

  3. IAFFALDANO P, Lucisano G, Guerra T, Patti F, et al
    Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
    Mult Scler. 2022 Aug 15:13524585221114007. doi: 10.1177/13524585221114007.
    PubMed         Abstract available

    Nat Rev Neurol

  4. HOFTBERGER R, Lassmann H, Berger T, Reindl M, et al
    Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept.
    Nat Rev Neurol. 2022 Aug 15. pii: 10.1038/s41582-022-00700.
    PubMed         Abstract available

    Neurologia (Engl Ed)

  5. SHAYGANNEJAD V, Mirmosayyeb O, Vaheb S, Nehzat N, et al
    The prevalence of sexual dysfunction (SD) and erectile dysfunction (ED) in men with multiple sclerosis (MS): a systematic review and meta-analysis.
    Neurologia (Engl Ed). 2022 Aug 10. pii: S2173-5808(22)00088.
    PubMed         Abstract available

  6. GOMEZ-PINEDO U, Matias-Guiu JA, Torre-Fuentes L, Montero-Escribano P, et al
    Variant rs4149584 (R92Q) of the TNFRSF1A gene in patients with familial multiple sclerosis.
    Neurologia (Engl Ed). 2022 Aug 10. pii: S2173-5808(22)00087.
    PubMed         Abstract available


  7. ROOS I, Malpas C, Leray E, Casey R, et al
    Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022 Aug 17. pii: WNL.0000000000201029.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.